Abstract:Cross-talk between sterol metabolism and inflammatory pathways has been demonstrated to significantly affect the development of atherosclerosis. Cholesterol biosynthetic intermediates and derivatives are increasingly recognized as key immune regulators of macrophages in response to innate immune activation and lipid overloading. 25-Hydroxycholesterol (25-HC) is produced as an oxidation product of cholesterol by the enzyme cholesterol 25-hydroxylase (CH25H) and belongs to a family of bioactive cholesterol derivatives produced by cells in response to fluctuating cholesterol levels and immune activation. Despite the major role of 25-HC as a mediator of innate and adaptive immune responses, its contribution during the progression of atherosclerosis remains unclear. The levels of 25-HC were analyzed by liquid chromatography-mass spectrometry, and the expression of CH25H in different macrophage populations of human or mouse atherosclerotic plaques, respectively. The effect of CH25H on atherosclerosis progression was analyzed by bone marrow adoptive transfer of cells from wild-type or Ch25h –/– mice to lethally irradiated Ldlr –/– mice, followed by a Western diet feeding for 12 weeks. Lipidomic, transcriptomic analysis and effects on macrophage function and signaling were analyzed in vitro from lipid-loaded macrophage isolated from Ldlr –/– or Ch25h–/–;Ldlr–/– mice . The contribution of secreted 25-HC to fibrous cap formation was analyzed using a smooth muscle cell lineage–tracing mouse model, Myh11 ERT2CRE mT/mG;Ldlr –/– , adoptively transferred with wild-type or Ch25h –/– mice bone marrow followed by 12 weeks of Western diet feeding. We found that 25-HC accumulated in human coronary atherosclerotic lesions and that macrophage-derived 25-HC accelerated atherosclerosis progression, promoting plaque instability through autocrine and paracrine actions. 25-HC amplified the inflammatory response of lipid-loaded macrophages and inhibited the migration of smooth muscle cells within the plaque. 25-HC intensified inflammatory responses of lipid-laden macrophages by modifying the pool of accessible cholesterol in the plasma membrane, which altered Toll-like receptor 4 signaling, promoted nuclear factor-κB–mediated proinflammatory gene expression, and increased apoptosis susceptibility. These effects were independent of 25-HC–mediated modulation of liver X receptor or SREBP (sterol regulatory element–binding protein) transcriptional activity. Production of 25-HC by activated macrophages amplifies their inflammatory phenotype, thus promoting atherogenesis.

Cholesterol Enrichment Upregulates Intercellular Adhesion Molecule-1 in Human Vascular Endothelial Cells.

Cholesterol Increases Adhesion of Monocytes to Endothelium by Moving Adhesion Molecules out of Caveolae

Number and Activity of Endothelial Progenitor Cells from Peripheral Blood in Patients with Hypercholesterolaemia

Cholesterol binding to VCAM-1 promotes vascular inflammation

Effect of Homocysteine on Expression of Intercellular Adhesion Molecule-2 and Adhesion of Dendritic Cells to Cultured Human Umbilical Vein Endothelial Cells

Hypercholesterolaemic Serum Increases the Permeability of Endothelial Cells Through Zonula Occludens-1 with Phosphatidylinositol 3-Kinase Signaling Pathway

Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases.

Induction of vascular cell adhesion molecule-1 by low-density lipoprotein.

Monocyte-to-endothelial Cell Crosstalk By 27hydroxycholesterol Promotes Monocyte Vascular Recruitment And Thereby Advances Atherogenesis

7-Ketocholesterol Promotes Cholesterol Uptake and Inflammation in Macrophage: Potential Mechanisms of Dietary COP in Atherosclerosis Promotion

LDL induces transcription factor activator protein-1 in human endothelial cells.

Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis

Mixed Lineage Kinase Domain-Like Protein Promotes Human Monocyte Cell Adhesion to Human Umbilical Vein Endothelial Cells Via Upregulation of Intercellular Adhesion Molecule-1 Expression

Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice

Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling

Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins.

Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

Cholesterol Loading Increases the Translocation of ATP Synthase Β Chain into Membrane Caveolae in Vascular Endothelial Cells

Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis

Angiotensin II Decreases Cholesterol 27-Hydroxylase Expression and Promotes Foam Cell Formation in THP-1

Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial Cells